Back to SNDX
Versant Capital Management, Inc → SNDX
Versant Capital Management, Inc SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$16K
Q3 2026
Peak value
$20K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $13K |
| Q4 2025 | $18K |
| Q1 2026 | $20K |
| Q2 2026 | $18K |
| Q3 2026 | $16K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $16K | 844 | — | — |
| Q2 2026 | $18K | 844 | — | — |
| Q1 2026 | $20K | 844 | — | — |
| Q4 2025 | $18K | 844 | — | — |
| Q3 2025 | $13K | 844 | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M